
"Smart Quality — empowering life sciences companies to turn quality into a competitive advantage"
Founded
2017
9 years
Employees
51-200
Annual Revenue
Not Disclosed
(2026)
Products
1
Scilife N.V. is a Belgian, venture-backed cloud eQMS vendor founded in 2017 by Filip Heitbrink and focused exclusively on the life sciences industry. The company serves small-to-mid-size pharmaceutical, biotech, medical device, ATMP, healthcare logistics (GDP), and medicinal-cannabis manufacturers with a single pre-validated cloud platform — the **Smart Quality Platform** — hosted on Amazon Web Services and aligned to GAMP 5, 21 CFR Part 11, Annex 11, and a broad range of ICH and ISO standards. Scilife is headquartered in Brussels (EMEA: Louizalaan 489, 1050 Brussels) and operates a U.S. subsidiary at 228 E 45th St., New York, NY, open since March 2023. The company describes its workforce as 100% remote, with employees across Antwerp, Brussels, Barcelona, Jodhpur (India), and Miami.
In June 2024 Scilife received a growth investment from **Five Elms Capital** (Kansas City; $2.4B+ AUM), a software-focused growth-equity firm; the round size was not disclosed. Concurrent with the investment, founder Heitbrink moved to the Board of Directors and **Sebastien Sepierre** — previously Managing Director at hospitality-tech firm Fourth and a former IBM EMEA implementation leader — was appointed CEO. As of late 2025, LeadIQ records approximately 105+ employees across four continents, consistent with a net-hiring trajectory following the Five Elms investment. The company reports serving "over 200 customers worldwide" and is actively expanding its North American commercial presence.
Scilife is **life-sciences-specialized** and does not sell into non-regulated industries. Its target segments include pharmaceutical/biotech, medical devices, ATMP (advanced therapy medicinal products), healthcare logistics (GDP-regulated 3PLs), medicinal cannabis, and CRO/CMO organizations. As of the 2024 CEO transition announcement, Scilife reports serving "over 200 customers worldwide," described in the Five Elms funding release as "hundreds of life sciences companies"; a pharma-only customer subtotal is not disclosed.
Publicly disclosed named customers include: **Novartis** (Big Pharma logo — scope of engagement undisclosed), **Polpharma, Qualiphar, Divasa-Farmavic** (mid-cap European pharma), **Pendulum Therapeutics, DNA Script, Coriolis Pharma, Biocartis, Helius Therapeutics** (specialized biotech/CDMO), **OGT (Oxford Gene Technology), Idevax, Amnovis, miDiagnostic** (medical device/diagnostics), **Qualifyze** (supplier-audit platform), **Yusen Logistics, Duomed** (healthcare logistics/distribution), and case-study customers **Inovet, White Raven, Peilivision, De Ceunynck** (homepage logos, accessed 2026-05-14). Pendulum Therapeutics is cited as a four-year customer. The Idevax case study reports ISO 13485 certification obtained within 18 months of deploying Scilife. Scilife's pharma page explicitly supports veterinary and medicinal cannabis manufacturers. Regulations explicitly supported include FDA 21 CFR Part 11/210/211/820 (QMSR), EU GMP Annex 11, ICH Q8/Q9/Q10, GMP/GDP/GLP/GCP, GAMP 5, ISO 9001/13485/14971/15189/17025, EU MDR/IVDR, UK MDR/IVDR, and MDSAP. Vendor reports most pharma customers go live in approximately 90 days.
Industries Served
Scilife is a privately held company and does not disclose revenue, ARR, valuation, or profitability. PitchBook lists current revenue as blank. The sole disclosed funding event is a strategic growth investment from **Five Elms Capital** announced June 7, 2024; the round size was not disclosed. Five Elms Capital is a Kansas City-headquartered growth-equity firm with $2.4B+ in AUM specializing in B2B software — it is Scilife's only disclosed institutional investor on record (Crunchbase, Tracxn). The investment was characterized as a "strategic growth investment" to fund continued product innovation (including the Design & Development module shipped in July 2025) and North American commercial expansion.
No M&A activity by Scilife — neither acquisitions made nor a sale process — has been publicly reported as of the essay date. The company is actively recruiting for a VP of Finance role (ZoomInfo, accessed 2026-05-14), consistent with a professionalizing finance function following PE-style growth investment. Headcount grew from "more than 70" employees (mid-2024 CEO transition release) to approximately 105+ (LeadIQ, October 2025), indicating post-investment net hiring. Vendor-reported efficiency claims — "up to 50% reduction in compliance costs" and "up to 30% faster time-to-market" — appear in the Five Elms press release but are vendor-reported figures without independent verification.
Browse all software products offered by Scilife.
Scilife sells one cloud platform — the **Smart Quality Platform** — packaged as three named products. The flagship **Smart QMS** is a comprehensive eQMS covering: document control, training management, quality events/deviations, CAPA management, change control, audits management, risk management (with built-in FMEA), supplier management, equipment and calibration management, and quality KPI dashboards. **Smart QMS for Medical Devices** adds Design & Development capabilities aligned to ISO 13485 and FDA 21 CFR Part 820 (QMSR), including structured design-control workflows, an automated traceability matrix, version-comparison tooling, and Part 11 e-signatures; this module launched July 15, 2025 as v1.0.0. The third product, **Controlled Printing and Reconciliation**, is a 21 CFR Part 11-compliant printing/reconciliation module with barcode support.
The platform is **modular within a single suite** — customers select the modules they need and activate more as they grow. It is hosted on AWS with files replicated across three global S3 locations, and Scilife's GAMP 5 pre-validation ships a customer-usable validation documentation set (drafted, executed, signed-off), which Scilife claims lifts "95% of the validation burden" from customers. License classes include full users and read-only users (the latter can sign training but cannot author documents). Pricing is annual subscription with a free tier and tiered plans; 1 GB storage is included and overages billed separately. Public marketing references "advanced data analytics," "augmented learning," and "gamification" as differentiating capabilities. No generative-AI or machine learning feature (e.g., AI-assisted CAPA root-cause, AI document summarization) is named on public product pages as of the essay date. The Scilife Academy (academy.scilife.io) and Community ("Masterminds") portal complement the product with structured learning and peer Q&A.
Scilife's integration surface is documented on its integrations page (scilife.io/solution/integrations, accessed 2026-05-14). **Cloud and identity:** the platform is hosted on AWS with files in Amazon S3 (three-location global replication); single sign-on is via **Microsoft Entra ID (Azure AD)** with **SCIM** for automated user provisioning. **Analytics/BI:** a secure, read-only database connector is available for **Power BI** and **Tableau**. **ERP:** a productized integration with **Microsoft Dynamics NAV (Navision)** synchronizes Products and Services and Contacts master data. **API:** a token-based REST API covers documents, trainings, events, CAPAs, audits, and related objects for custom integrations. Scilife has no pre-built connector to a pharma LIMS (LabWare, LabVantage, STARLIMS), pharma ERP (SAP S/4HANA), or MES system (Werum PAS-X, Körber, Tulip). It has no AWS Marketplace, Azure Marketplace, or Salesforce AppExchange listing.
Scilife operates a **partnership program** for life-sciences consultancies, validation experts, and regulatory-affairs partners, announced in a press release (https://www.scilife.io/press-releases/new-partnership-program). However, no named Tier-1 SI relationships (Deloitte, Accenture, Capgemini, IBM, PwC, EY, TCS, Cognizant) are publicly disclosed, and specific named boutique partners are not listed on the public partners page. Industry organizational memberships (ISPE, PDA, PQG, GS1, USP) are not cited on public Scilife pages.
Cloud Partners
Technology Partners
Customer support is included in the subscription at no extra fee across all plans (scilife.io/price). Specific 24/7 coverage commitments, response SLAs, and regional language support are not published on public pages. Customer case studies repeatedly cite named Customer Success Managers (Trine Michelsen cited in the Idevax case study; Fabiola Samueli cited in the Pendulum case study), indicating a named-CSM model is in use, though the formal CSM tier structure is not disclosed publicly.
Scilife provides three public-facing learning surfaces: (1) the **Knowledge Base** at support.scilife.io; (2) the **Scilife Academy** (video lessons and certificates) at academy.scilife.io; and (3) the **Scilife Community ("Masterminds")** for peer Q&A, feature requests, and roadmap upvoting (launched per press release). Scilife also runs an annual **Smart Quality Summit** conference and participates as an exhibitor at **CPHI Frankfurt** (2025). A GAMP 5 validation documentation package (drafted, executed, signed-off) is included for customer use, and Scilife claims to lift "95% of the validation burden" via its pre-validated AWS platform. Industry-specific onboarding templates are available for pharma/biotech, medical devices, healthcare logistics (GDP), and medicinal cannabis. Vendor reports most pharma customers go live in approximately 90 days. A formal certification program for end-users or implementation partners is not publicly named.
Scilife holds **ISO 9001** certification, publicly displayed via a footer link on scilife.io (https://www.scilife.io/company/iso-9001-certification). The platform is **GAMP 5-validated** on AWS infrastructure and ships a customer-usable validation documentation package. **ISO 27001** certification and **SOC 2 Type II** report availability are undisclosed on Scilife's security pages and other public references. The company relies on AWS's underlying compliance for infrastructure-level certifications.
Scilife received **G2 Spring 2022 High Performer** (Medical QMS and Pharma & Biotech Software) and **G2 Summer 2022 Leader** (Pharma & Biotech) placements, which Scilife cites in its own press releases. As of the essay date, SelectHub's aggregation reports an **86% user-satisfaction average across 82 reviews** from G2, Capterra, and Software Advice combined; user-reported strengths include ease of use, breadth of modules in a single platform, GAMP 5/21 CFR Part 11 alignment, and quality of customer support; user-reported weaknesses include search/filter ergonomics, occasional bugs from frequent release cadence, and a UI some find dense. Scilife is not currently named in a Gartner Magic Quadrant, Forrester Wave, IDC MarketScape, KLAS, or Verdantix Green Quadrant. Leadership: CEO **Sebastien Sepierre** (appointed 2024; formerly MD at Fourth, IBM EMEA); founder and Board member **Filip Heitbrink**; technology leadership **Roozbeh Farahbod** (named in the D&D launch press release). Thought leadership includes a high-frequency blog, a glossary, an annual **Global Quality Outlook** (2026 edition published), regular webinars, a Quality Maturity Scan, and an ROI calculator.
Scilife maintains an actively maintained HubSpot-hosted website with a refreshed product taxonomy (2025–2026), running 2026 copyright notices on current product pages. The press-release index shows a moderate-but-consistent cadence of approximately 4–6 substantive releases per year, primarily around product launches and corporate milestones: the most recent is the Design & Development module launch (July 16, 2025), preceded by a September 2024 release, the Five Elms investment announcement (June 2024), and the CEO transition (2024). The company has **40,000+ LinkedIn followers** on its Belgian LinkedIn page and publishes regular content. Scilife runs its own annual **Smart Quality Summit** conference and exhibited at **CPHI Frankfurt 2025**.
Scilife's "Smart Quality" positioning narrative recasts QA from a compliance cost center into a value-creation function via analytics, learning, and gamification. Vendor-reported marketing claims include "up to 50% reduction in compliance costs" and "up to 30% faster time-to-market" (Five Elms PR Newswire announcement). The company provides product demos, an ROI calculator, a Quality Maturity Scan, a free-tier subscription, and extensive educational content (Global Quality Outlook 2026, webinars, blog, glossary). Scilife is listed and reviewed on G2, Capterra, and Software Advice (legacy "QualityKick" listing on Capterra/Software Advice), and appears in SelectHub's QMS comparison aggregator. Direct competitor comparison pages are published at scilife.io/product/compare.
Headquarters
Brussels, unknown, Belgium
Founded
2017 (9 years in business)
Company Size
51-200 employees
Type
Private
Owned by unknown
Annual Revenue
Not Disclosed (2026)
Office Locations